NeoGenomics, Inc. Convertible Debt, Noncurrent
NeoGenomics, Inc. (NEO) had Convertible Debt, Noncurrent of $374.24 million as of 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent › Long-Term Debt and Lease Obligation › Long-Term Debt, Excluding Current Maturities
us-gaap:ConvertibleDebtNoncurrent · last filed 2026-07-28
- 2026-06-30: Convertible Debt, Noncurrent $374.24M.
- 2026-03-31: Convertible Debt, Noncurrent $342.24M.
- 2025-12-31: Convertible Debt, Noncurrent $341.86M.
- 2025-09-30: Convertible Debt, Noncurrent $341.48M.
| Period end | Convertible Debt, Noncurrent |
|---|---|
| 2026-06-30 | $374.24M 10-Q · filed 2026-07-28 |
| 2026-03-31 | $342.24M 10-Q · filed 2026-04-28 |
| 2025-12-31 | $341.86M 10-Q · filed 2026-07-28 |
| 2025-09-30 | $341.48M 10-Q · filed 2025-10-28 |
| 2025-06-30 | $341.10M 10-Q · filed 2025-07-29 |
| 2025-03-31 | $340.71M 10-Q · filed 2025-04-29 |
| 2024-12-31 | $340.33M 10-K · filed 2026-02-17 |
| 2024-09-30 | $339.96M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $339.58M 10-Q · filed 2024-07-30 |
| 2024-03-31 | $538.92M 10-Q · filed 2024-04-30 |
| 2023-12-31 | $538.20M 10-K · filed 2025-02-18 |
| 2023-09-30 | $537.48M 10-Q · filed 2023-11-06 |
| 2023-06-30 | $536.75M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $536.04M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $535.32M 10-K · filed 2024-02-20 |
| 2022-09-30 | $534.61M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $533.90M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $533.19M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $532.48M 10-K · filed 2023-02-24 |
| 2021-09-30 | $531.78M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $531.08M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $530.38M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $168.12M 10-K · filed 2022-02-25 |
| 2020-09-30 | $166.44M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $164.54M 10-Q · filed 2020-07-31 |
| 2019-12-31 | $0.00 10-K · filed 2021-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| 20/20 Biolabs, Inc. (AIDX) | United States | $0.005B |